Product Description:

Fulvestrant is an injection used to treat hormone receptor-positive metastatic breast cancer. The injection comes in a single vial containing 500mg/5ml of fulvestrant. Fulvestrant is administered intramuscularly once every 28 days at a dosage of 250mg. Fulvestrant is typically used in patients who no longer respond to anti-estrogen treatments or who have developed a resistance to them. It works by blocking the effects of the hormone estrogen in the body, ultimately leading to the reduction of tumor size. Fulvestrant is a safe and effective treatment for hormone receptor-positive metastatic breast cancer, and it has been proven to reduce the risk of further progression of the disease.

Features:

• Product Name: Fulvestrant
• Indication: Treatment Of Hormone Receptor-positive Metastatic Breast Cancer
• Pack Size: 1 Vial
• Administration: Intramuscular
• Active Ingredient: Fulvestrant
• Dosage: 250mg Intramuscularly Once Every 28 Days
• Other Name: Faslodex, Fulvestrant Injection, Faslodex Injection, Estrogen Receptor Antagonist

Applications:

Fulvestrant, also known as Faslodex Injection, is a 500mg injection manufactured by Pfizer and indicated for the treatment of hormone receptor-positive metastatic breast cancer. This medication should not be used in pregnant or breastfeeding women. It has a shelf life of 36 months.

Fulvestrant has been proven to be effective in treating hormone receptor-positive metastatic breast cancer. It works by blocking the action of estrogen in the body, which can reduce the growth and spread of cancer cells. It is usually administered as an intramuscular injection once every two weeks. The dosage and duration of treatment will depend on the individual patient's response to the medication.

It is important to discuss any potential risks and side effects with your doctor before starting treatment with fulvestrant. Common side effects include hot flashes, nausea, vomiting, headache, and fatigue. Serious side effects can include allergic reactions, difficulty breathing, chest pain, and irregular heartbeat. It is important to seek medical attention immediately if you experience any of these symptoms.

Fulvestrant has been found to be an effective treatment option for hormone receptor-positive metastatic breast cancer. However, it is important to discuss any potential risks and side effects with your doctor before starting treatment. Additionally, pregnant or breastfeeding women should not use this medication. With proper use, Fulvestrant can help provide relief for patients suffering from this type of cancer.

Customization:

Support and Services:

Fulvestrant Technical Support and Service

• Product information and technical specifications
• Installation and configuration instructions and assistance
• Troubleshooting and technical support of Fulvestrant
• Software updates and patches
• Maintenance and warranty services

Packing and Shipping:

Packaging and Shipping for Fulvestrant:

Fulvestrant should be packaged in its original container, which should be sealed and stored in a cool, dry place. The temperature should not exceed 25°C (77°F). The container should not be exposed to direct sunlight or any other light source. Fulvestrant should be shipped in accordance with local, state, and national regulations. It should be shipped on a cold pack or in an insulated container with appropriate insulation material to maintain the temperature below 25°C (77°F).

FAQ:

Q: What is Fulvestrant?

A: Fulvestrant is an injectable medication used to treat certain types of breast cancer in postmenopausal women.

Q: How does Fulvestrant work?

A: Fulvestrant works by blocking the effects of the hormone estrogen on cancer cells. This can slow or stop the growth of tumors.

Q: What are the side effects of Fulvestrant?

A: Common side effects of Fulvestrant include joint pain, headache, nausea, and hot flashes.

Q: Who should not take Fulvestrant?

A: Fulvestrant is not recommended for women who are pregnant or breastfeeding. Women who are allergic to any of the ingredients in Fulvestrant should not take it.

Q: How should Fulvestrant be taken?

A: Fulvestrant should be taken as directed by your doctor. It is usually given as an injection into the muscle of the buttocks, usually once a month.